| 866541-93-7 | (R)-(-)-Gossypol acetic acid | AT101 | C32H34O10 | 578.606370449066 |
| 1071992-99-8 | AT-406 | AT-406 | C32H43N5O4 | 561.714927911758 |
| 90141-22-3 | AT 101 | (-)-棉子素 | C30H30O8 | 518.554409503937 |
| 79183-19-0 | MDK83190 | 1-(3,4-二氯苄基)-1H-吲哚-2,3-二酮 | C15H9Cl2NO2 | 306.143461942673 |
| 852808-04-9 | Abt-737 | 4-[4-[(4'-氯-联苯-2-基)甲基]哌嗪-1-基]-N-[[4-[[(1R)-3-(二甲胺基)-1-[(苯基硫基)甲基]丙基]氨基]-3-硝基苯基]磺酰基]苯甲酰胺 | C42H45ClN6O5S2 | 813.426906347275 |
| 4311-88-0 | Necrostatin-1 | Necrostatin-1 抑制剂 | C13H13N3OS | 259.326821088791 |
| 675576-97-3 | Nutlin-3b | NUTLIN 3B 抑制剂 | C30H30Cl2N4O4 | 581.489605426788 |
| 548472-68-0 | Nutlin-3 | 4-[4,5-双(4-氯苯基)-2-(4-甲氧基-2-异丙氧基苯基)-4,5-二氢咪唑-1-羰基]哌嗪-2-酮 | C30H30Cl2N4O4 | 581.489605426788 |
| 58131-57-0 | NSC-207895 | 4-(4-甲基-1-哌嗪基)-7-硝基-2,1,3-苯并二唑 3-氧化物 | C11H13N5O4 | 279.252021551132 |
| 890090-75-2 | Nutlin-3 | 4-[[4,5-双(4-氯苯基)-4,5-二氢-2-[4-甲氧基-2-(1-甲基乙氧基)苯基]-1H-咪唑-1-基]羰基]-2-哌嗪酮 | C30H30Cl2N4O4 | 581.489605426788 |
| 71555-25-4 | NSC319726 | 1-吖丁啶硫代羧酸[1-(2-吡啶基)亚乙基]酰肼 | C11H14N4S | 234.32 |
| 675576-98-4 | Nutlin-3A | Nutlin-3A 抑制剂 | C30H30Cl2N4O4 | 581.489605426788 |
| 803712-79-0 | Obatoclax Mesylate | Obatoclax 甲磺酸盐 | C21H23N3O4S | 413.490023851395 |
| 63208-82-2 | Pifithrin-α hydrobromide | 2-(2-亚氨基-4,5,6,7-四氢苯并噻唑-3-基)-1-P-苯甲基乙酮氢溴酸盐 | C16H19BrN2OS | 367.303861856461 |
| 137281-23-3 | Pemetrexed | 培美曲塞二钠盐 | C20H21N5O6 | 427.4106 |
| 19171-19-8 | Pomalidomide | 泊马度胺 | C13H11N3O4 | 273.2441 |
| 315183-21-2 | PAC-1 | PAC-1 | C23H28N4O2 | 392.494025230408 |
| 939981-39-2 | RG7112 | [(4R,5S)-4,5-双(4-氯苯基)-2-[4-(1,1-二甲基乙基)-2-乙氧基苯基]-4,5-二氢-4,5-二甲基-1H-咪唑-1-基][4-[3-(甲磺酰基)丙基]-1-哌嗪基]甲酮 | C38H48Cl2N4O4S | 727.783126831055 |
| 882531-87-5 | R1530 | 5-(2-chlorophenyl)-7-fluoro-8-methoxy-3-methyl-1,2-dihydropyrazolo[3,4-b][1,4]benzodiazepine | C18H14ClFN4O | 356.781365871429 |
| 213261-59-7 | RITA | RITA (NSC 652287) 抑制剂 | C14H12O3S2 | 292.373281478882 |
| 1096687-52-3 | SPK-601 | 二硫代碳酸 rel-(-)-O-[(3aR,4R,5S,7R,7aR)-八氢-4,7-甲桥-1H-茚-5-基]酯钾盐 | C11H15KOS2 | 266.464501619339 |
| 143360-00-3 | SMIP004 | N1-(4-丁基-2-甲基苯基)乙酰胺 | C13H19NO | 205.296063661575 |
| 204005-46-9 | SU 5416 | 7-氟-6-硝基-4-羟基喹唑啉 | C15H14N2O | 238.2845 |
| 380315-80-0 | TENOVIN-1 | N-[[[4-(乙酰氨基)苯基]氨基]硫代甲酰]-4-叔丁基苯甲酰胺 | C20H23N3O2S | 369.480523347855 |
| 50-35-1 | Thalidomide | 沙利度胺 | C13H10N2O4 | 258.2295 |
| 877877-35-5 | TW-37 | TW-37 抑制剂 | C33H35NO6S | 573.699108362198 |
| 114899-77-3 | Trabectedin | 他比特定 | C39H43N3O11S | 761.837229967117 |
| 781661-94-7 | Sepantronium bromide | YM155 抑制剂 | C20H19BrN4O3 | 443.293863534927 |
| 1431866-33-9 | WEHI 539 | WEHI539 抑制剂 | C31H29N5O3S2 | 583.723664045334 |
| 331244-89-4 | BAM7 | BAM7 抑制剂 | C21H19N5O2S | 405.472862482071 |
| 218600-44-3 | Bardoxolone | 2-氰基-3,12-二氧代齐墩果-1,9-二烯-28-酸 | C31H41NO4 | 491.661549329758 |
| 83373-60-8 | Carbonodithioic Acid O-(Octahydro-4,7-methano-1H-inden-5-yl) Ester Potassium Salt | D609 | C11H16KOS2 | 267.472441673279 |
| 1260251-31-7 | Birinapant | 比瑞那帕 | C42H56F2N8O6 | 806.940856933594 |
| 1257044-40-8 | Venetoclax | 维奈妥拉 | C45H50ClN7O7S | 868.439208507538 |
| 873652-48-3 | Gdc-0152 | GDC 0152 | C25H34N6O3S | 498.640863895416 |
| 65673-63-4 | HA14-1 | 乙基-2-氨基-6-溴-4-(1-氰基-2-乙氧基-2-甲酰)-4H-苯并呋喃-3-羧酸 | C17H17BrN2O5 | 409.231283903122 |
| 1005342-46-0 | LCL161 | LCL161 抑制剂 | C26H33FN4O3S | 500.628628492355 |
| 191732-72-6 | Lenalidomide | 来那度胺 | C13H13N3O3 | 259.260622739792 |
